Abbott and Novo Nordisk strike diabetes digital solution deal
Abbott and Novo Nordisk have entered into a partnership to provide integrated digital solutions to people with diabetes, using insulin.
Read More
Tag: FreeStyle Libre
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
